Press Releases
A trial of one of Igen Biolab Group’s products to investigate Age-Related Macular Degeneration (AMD) is approved
Javier Asarta, CEO of the Igen Biolab Group: “AMD affects some 700,000 people in Spain and currently has no treatment”.Dr Jordi Monés, study author: “As well as the medical benefits for patients, it reduces the socio-economic burden by preventing or improving the...
Biotech company Igen Biolab Group to raise up to EUR 15m for its clinical trials on lung cancer
Madrid, April 25, 2019.- Igen Biolab Group, a Spanish-based biotech company focused on the study of the microbiota impact on the prevention and treatment of cancer, and of neurodegenerative and metabolic diseases, has opened a financing round of up to 15 million euros...
New sponsorship for culture by IGEN Biotech
Among his Corporate Social Responsibility strategy, IGEN Biotech has expanded his programs of sponsorship on culture with a new agreement with the Culture Department of the regional Government of Catalonia (Spain), the Council of Barcelona, La Vanguardia,...
IGEN Biotech bets for culture in Madrid
IGEN Biotech has renewed for a second season its commitment, within its Corporate Social Responsibility strategy, sponsorship society cycle of concerts "La Filarmónica" at the National Auditorium in Madrid. The concerts of the cycle will be given by...
Sponsorship agreement between IGEN Biotech Group and ‘La Filarmónica’
IGEN Biotech Group has signed a sponsorship agreement with the concert society 'La Filarmónica' as a partner of the third season of the concert series that will run from October 2014 to February 2015 at the National Auditorium and the Teatro Real in...
